CPG
JAZZ icon

Cornerstone Planning Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cornerstone Planning Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33K Hold
11
– – ﹤0.01% 1266
2025
Q4 		$1.82K Hold
11
– – ﹤0.01% 1211
2025
Q3 		$1.5K Hold
11
– – ﹤0.01% 1218
2025
Q2 		$1.25K Hold
11
– – ﹤0.01% 1060
2025
Q1 		$1.15K Buy
11
+4
+57% +$522 ﹤0.01% 1102
2024
Q4 		$871 Buy
+7
New +$825 ﹤0.01% 986
2023
Q3 		– Sell
-11
Closed -$1.36K – 1259
2023
Q2 		$1.36K Buy
+11
New +$1.48K ﹤0.01% 1281
2022
Q4 		$1.25K Buy
+8
New +$1.17K ﹤0.01% 1309

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cornerstone Planning Group's JAZZ Position: Q1 2026 in Review

Cornerstone Planning Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 11 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Cornerstone Planning Group first reported a position in JAZZ in Q4 2022 and has held it in 8 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Cornerstone Planning Group held 11 shares of Jazz Pharmaceuticals worth $2.33K as of Q1 2026.
  • Cornerstone Planning Group left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #1266 holding.
  • Cornerstone Planning Group first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.